KWF Kankerbestrijding
BOOST (Bridging Obstacles for Optimal model use via Shared Technical expertise)
Deadline inferred from reference to 1 July 2026 cut-off; participating institutes not yet registered must submit registration request at least 6 weeks prior to closing date
Last verified:
Details
| Funder | KWF Kankerbestrijding |
| Budget | ~€150,000 per project |
| Deadline | 1 July 2026 |
| Duration | 6-24 months |
| Consortium | No |
| Application | Single stage: full-proposal only |
| TRL | 3+ |
| Eligible countries | NL |
Eligibility & scope
Open to researchers with an ongoing or recently finished KWF drug research project (start ≥6 months ago, end ≤1.5 years before 1 July 2026). Funds access to clinically relevant preclinical models, technologies and expertise (e.g. NAMs, PDX, organoids, CROs) to improve translational value. Dutch institutions only; commercial partner involvement requires a letter of intent.
Related on Grantsby
- KWF Kankerbestrijding writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free